Jul 14, 2025, 15:10
Patrick Soon-Shiong: Pharma is Investing in China and USA Biotech is at Risk
Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:
“Unless we wake up, China’s speed in regulatory approval is their advantage, we will lose our lead and be dependent on next generation drugs from rest of world.
Urgent need to change old world regulatory bureaucracy.
Pharma is investing in China and USA biotech at risk.”
More posts featuring Pharma.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 14, 2025, 15:43
Jul 14, 2025, 15:39
Jul 14, 2025, 15:23
Jul 14, 2025, 15:17
Jul 14, 2025, 15:10